Literature DB >> 22146151

Is the Gly82Ser polymorphism in the RAGE gene relevant to schizophrenia and the personality trait psychoticism?

Petra Suchankova1, Jonas Klang, Carin Cavanna, Göran Holm, Staffan Nilsson, Erik G Jönsson, Agneta Ekman.   

Abstract

BACKGROUND: The receptor for advanced glycation end products (RAGE) is the main receptor for S100B, an astrogial proinflammatory mediator that has been suggested to be involved in the pathophysiology of schizophrenia. To further elucidate the possible relevance of inflammation for mental functions, we investigated a functional polymorphism in the gene coding for RAGE in relation to personality traits and susceptibility to schizophrenia.
METHODS: We studied the Gly82Ser polymorphism (rs2070600, 244G>A) in 2 population-based cohorts of middle-aged participants assessed using the Karolinska Scales of Personality. In addition, we compared genotype frequencies between patients with schizophrenia and controls.
RESULTS: The population-based cohorts included 270 women and 247 men, and the case-control study involved 138 patients with schizophrenia and 258 controls. In the population-based cohorts, 82Ser carriers were found to have significantly higher scores for the psychoticism personality trait comprising the detachment and suspicion subscales. The case-control study revealed that the 82Ser allele was significantly more frequent among patients than controls. LIMITATIONS: This study was limited by the modest sample size and the use of a self-report measure to assess personality traits.
CONCLUSION: Our findings suggest that the proven relation between certain personality traits and schizophrenia can at least to some extent be explained on a genetic level. Also, the activated S100B-RAGE axis may be an underlying cause, not only a consequence, of the disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22146151      PMCID: PMC3297072          DOI: 10.1503/jpn.110024

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  46 in total

Review 1.  RAGE: a multi-ligand receptor unveiling novel insights in health and disease.

Authors:  P Alexiou; M Chatzopoulou; K Pegklidou; V J Demopoulos
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

2.  Enhanced carbonyl stress in a subpopulation of schizophrenia.

Authors:  Makoto Arai; Hiroko Yuzawa; Izumi Nohara; Tetsuo Ohnishi; Nanako Obata; Yoshimi Iwayama; Seiichi Haga; Tomoko Toyota; Hiroshi Ujike; Mayumi Arai; Tomoe Ichikawa; Atsushi Nishida; Yoko Tanaka; Aizo Furukawa; Yuuzou Aikawa; Osamu Kuroda; Kazuhiro Niizato; Ryosuke Izawa; Kazuhiko Nakamura; Norio Mori; Daisuke Matsuzawa; Kenji Hashimoto; Masaomi Iyo; Ichiro Sora; Masaaki Matsushita; Yuji Okazaki; Takeo Yoshikawa; Toshio Miyata; Masanari Itokawa
Journal:  Arch Gen Psychiatry       Date:  2010-06

Review 3.  The genetics of neurodevelopmental disease.

Authors:  Kevin J Mitchell
Journal:  Curr Opin Neurobiol       Date:  2010-09-09       Impact factor: 6.627

Review 4.  Temperament, personality and developmental psychopathology: a review based on the conceptual dimensions underlying childhood traits.

Authors:  Sarah S W De Pauw; Ivan Mervielde
Journal:  Child Psychiatry Hum Dev       Date:  2010-06

5.  Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology.

Authors:  M Rothermundt; U Missler; V Arolt; M Peters; J Leadbeater; M Wiesmann; S Rudolf; K P Wandinger; H Kirchner
Journal:  Mol Psychiatry       Date:  2001-07       Impact factor: 15.992

Review 6.  The biology of the receptor for advanced glycation end products and its ligands.

Authors:  A M Schmidt; S D Yan; S F Yan; D M Stern
Journal:  Biochim Biophys Acta       Date:  2000-12-20

Review 7.  Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes.

Authors:  P I Lin; A R Shuldiner
Journal:  Schizophr Res       Date:  2010-09-15       Impact factor: 4.939

8.  Genetic variability within the S100B gene influences the personality trait self-directedness.

Authors:  Petra Suchankova; Fariba Baghaei; Roland Rosmond; Göran Holm; Henrik Anckarsäter; Agneta Ekman
Journal:  Psychoneuroendocrinology       Date:  2010-11-26       Impact factor: 4.905

9.  Increased serum S100B protein in schizophrenia: a study in medication-free patients.

Authors:  D R Lara; C S Gama; P Belmonte-de-Abreu; L V Portela; C A Gonçalves; M Fonseca; S Hauck; D O Souza
Journal:  J Psychiatr Res       Date:  2001 Jan-Feb       Impact factor: 4.791

10.  Association of the RAGE G82S polymorphism with Alzheimer's disease.

Authors:  Jonny Daborg; Malin von Otter; Annica Sjölander; Staffan Nilsson; Lennart Minthon; Deborah R Gustafson; Ingmar Skoog; Kaj Blennow; Henrik Zetterberg
Journal:  J Neural Transm (Vienna)       Date:  2010-06-22       Impact factor: 3.575

View more
  10 in total

Review 1.  The Role of Brain Microvascular Endothelial Cell and Blood-Brain Barrier Dysfunction in Schizophrenia.

Authors:  Sovannarath Pong; Rakesh Karmacharya; Marianna Sofman; Jeffrey R Bishop; Paulo Lizano
Journal:  Complex Psychiatry       Date:  2020-09-14

2.  Increased receptor for advanced glycation end product expression in the human alcoholic prefrontal cortex is linked to adolescent drinking.

Authors:  Ryan P Vetreno; Liya Qin; Fulton T Crews
Journal:  Neurobiol Dis       Date:  2013-07-15       Impact factor: 5.996

3.  Psychopathy, adaptation, and disorder.

Authors:  Daniel Brian Krupp; Lindsay A Sewall; Martin L Lalumière; Craig Sheriff; Grant T Harris
Journal:  Front Psychol       Date:  2013-03-27

Review 4.  Neuroinflammation and psychiatric illness.

Authors:  Souhel Najjar; Daniel M Pearlman; Kenneth Alper; Amanda Najjar; Orrin Devinsky
Journal:  J Neuroinflammation       Date:  2013-04-01       Impact factor: 8.322

5.  Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study.

Authors:  Nisa M Maruthur; Man Li; Marc K Halushka; Brad C Astor; James S Pankow; Eric Boerwinkle; Josef Coresh; Elizabeth Selvin; Wen Hong Linda Kao
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

6.  Association of Polymorphisms of the Receptor for Advanced Glycation Endproducts Gene with Schizophrenia in a Han Chinese Population.

Authors:  Jiawu Fu; Xiang Zuo; Jingwen Yin; Xudong Luo; Zheng Li; Juda Lin; Bin Zhao; Guoda Ma; Keshen Li
Journal:  Biomed Res Int       Date:  2017-03-08       Impact factor: 3.411

Review 7.  Pathological Implications of Receptor for Advanced Glycation End-Product (AGER) Gene Polymorphism.

Authors:  Marine Serveaux-Dancer; Matthieu Jabaudon; Isabelle Creveaux; Corinne Belville; Raïko Blondonnet; Christelle Gross; Jean-Michel Constantin; Loïc Blanchon; Vincent Sapin
Journal:  Dis Markers       Date:  2019-02-04       Impact factor: 3.434

8.  MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients.

Authors:  Daniella Dwir; Basilio Giangreco; Lijing Xin; Liliane Tenenbaum; Jan-Harry Cabungcal; Pascal Steullet; Audrey Goupil; Martine Cleusix; Raoul Jenni; Abdelwahed Chtarto; Philipp S Baumann; Paul Klauser; Philippe Conus; Rabindra Tirouvanziam; Michel Cuenod; Kim Q Do
Journal:  Mol Psychiatry       Date:  2019-03-25       Impact factor: 15.992

9.  Levels of S100B are raised in female patients with schizophrenia.

Authors:  Kara O'Connell; Jogin Thakore; Kumlesh K Dev
Journal:  BMC Psychiatry       Date:  2013-05-24       Impact factor: 3.630

10.  Is psychopathy a disorder or an adaptation?

Authors:  Liane J Leedom; Linda Hartoonian Almas
Journal:  Front Psychol       Date:  2012-12-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.